NEWSROOM

Press Releases

In the News

Logo & Resources Library

Recent News

Summary Highlights of Important Research Presented at ACR Convergence 2023

New York, NY, November 29, 2023 — At the recent ACR Convergence 2023, the annual meeting of the American College...

Positive One-Year Results of PALS Program Published in Prestigious Rheumatology Journal

New York, NY, Oct. 26, 2023 — Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is...

Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis

New York, NY, October 17, 2023 — Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced...

Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment Efforts in SLE Through LuCIN Lupus Clinical Trial Network

NEW YORK, N.Y., Oct. 24, 2023 – Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announces a...

Lupus Therapeutics PALS Program Expansion

October 1, 2023 Call for Individuals to Serve as a Trained Peer Educator Lupus Therapeutics, the clinical affiliate of Lupus Research Alliance,...

Project CHANGE Launches Pilot Programs in Atlanta, Nashville, and Philadelphia to Increase Diversity in Lupus Clinical Research

New York, NY, June 29, 2023 — Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced...

Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE and Lupus Nephritis Through North American Trial Network

New York, NY, June 2, 2023 — Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3...

Investigational CAR T Cell Gets Fast Tracked by U.S. FDA

New York, NY, May 1, 2023 — The LRA and our clinical arm Lupus Therapeutics are pleased to share good news...

Lupus Research Alliance Appoints New Executive Vice President of Affiliate Lupus Therapeutics

New York, NY, January 17, 2023 — The Lupus Research Alliance (LRA) is pleased to announce the appointment of Stacie...

Promising Data Shows Lupus Research Alliance Peer Education Program Increases Intentions to Join Clinical Trials Among Diverse Patient Population

New York, NY, November 8, 2022 — ACR Convergence 2022 Included LRA-Authored Research on Measures to Demonstrate Treatment Efficacy for...

NIH Awards $500,000 to Advance to Advance Diversity in Lupus Trials

New York, NY, August 31, 2022 — We are excited to share good news – our Lupus Clinical Investigators Network,...

New England Journal of Medicine Publishes Positive Data of Litifilimab in Cutaneous Lupus Erythematosus

New York, NY, August 21, 2022 — We are pleased to share positive results from the two-part Phase 2 LILAC study...